Silva Pharmaceuticals Limited (DSE: SILVAPHL)
Health Care · Pharmaceuticals · BD
Tk10.40
-16.80% today · -1.9% 1Y
Silva Pharmaceuticals Limited (DSE: SILVAPHL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $11.53M.
Over the last twelve months the share price has lost 1.9%, trading between 7.60 and 18.00.
Tweenvest scores Silva Pharmaceuticals Limited across four factors: quality 63/100, value 50/100, growth 0/100. Its strongest factor is quality.
SILVAPHL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $11.53M
- Revenue (TTM)
- $2.69M
- P/E
- —
- EPS
- -1.13
- Dividend yield
- —
- Beta (5Y)
- -0.02
- 52-week high
- Tk18.00
- 52-week low
- Tk7.60
- Avg volume (3M)
- —
- Shares outstanding
- 136.50M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AcuCort AB (publ)XSAT: ACUC | $11.70M | Skr0.40 | -19.88% |
| Argenica Therapeutics LimitedASX: AGN | $11.65M | AU$0.13 | -13.33% |
| Aspire-Lakewood Holdings, Inc.NasdaqCM: ASBP | $11.64M | $7.64 | -7.95% |
| OncoZenge AB (publ)OM: ONCOZ | $11.54M | Skr3.79 | -9.33% |
| IDT Australia LimitedASX: IDT | $11.33M | AU$0.04 | -7.32% |
| Together Pharma LtdTASE: TGTR | $11.32M | ₪2.00 | -3.71% |
| Pharmaids Pharmaceuticals LimitedBSE: 524572 | $11.23M | Rs30.81 | +2.19% |
| Avicanna Inc.TSX: AVCN | $11.10M | CA$0.12 | +15.00% |
Figures last refreshed Oct 11, 2026.